Lantern Pharma to present Open-Medicine AI growth plan in live webinar today

Lantern Pharma Inc.

Webinar at 12:30 PM ET led by CEO Panna Sharma covering OMAI market, roadmap, economics, benchmarks, partnerships.
OMAI launched as withZeta.ai in April 2026 for rare cancers; ZetaOmics module added July 2026 for early-access users.
Platform monetized via subscription and enterprise licensing to biopharma, research institutions, and drug developers.
Session to include live demo, user feedback, key milestones, and shareholder-value discussion; replay available post-event.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.